PIHLAJALINNA OYJ |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.8 EUR | +7.84% |
|
+10.00% | +24.65% |
| 05-03 | Pihlajalinna Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-30 | Pihlajalinna Oyj Revises Earnings Guidance for the Year 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 12.05 for the current year.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company has a low valuation given the cash flows generated by its activity.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company does not generate enough profits, which is an alarming weak point.
- The company is in debt and has limited leeway for investment
- For the past year, analysts have significantly revised downwards their profit estimates.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +24.65% | 214M | C+ | ||
| +13.70% | 80.61B | C+ | ||
| -29.20% | 70.18B | B- | ||
| +9.86% | 29.08B | C+ | ||
| -11.43% | 16.97B | B | ||
| -0.43% | 16.96B | A- | ||
| -0.31% | 15.26B | A- | ||
| +3.42% | 12.41B | A- | ||
| -30.70% | 11.95B | - | - | |
| -6.75% | 11.93B | B- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- PIHLIS Stock
- Ratings Pihlajalinna Oyj
